Sahlgrenska Center for Cancer Research
Translational cancer research with the patient in focus
Here at Sahlgrenska Center for Cancer Research (SCCR) we focus our research with the patient in mind. This is so that the cancer patient could receive a better care in the future than in today’s society. Through a close collaboration with the Sahlgrenska University Hospital, we at the centre are trying to find new methods and treatments, which later can be tested and applied directly within the cancer care.
Our research groups work widely
Today our 26 research groups work in a wide spectrum of cancer related research questions, but they all have translational cancer research as a common denominator. Example of areas which are studied are brain cancers, lung cancer, breast cancer, melanoma, radiotherapy, prostate cancer and leukaemia. Other research areas at the centre are also epigenetics, ovarian and cervical cancer, sarcoma, neuroendocrine and thyroid cancers, pancreatic cancer and salivary gland tumors.
The research is in some cases used for developing diagnostic and prognostic tools, which in the longer term can improve the cancer care and ensure that the right treatments are being used.
Overbridging post graduate studies
Through the Cancer Research South (CARES) School we at Sahlgrenska Center for Cancer Research also provide courses within cancer research. As for our work, these courses are overbridging research and clinical work as well. CARES is a graduate research school which offers courses to PhD Students at University of Gothenburg and Lund University, which have both been part of the previous strategic program BioCARE.
Latest news
-
Health and medicineSEK 10M awarded for study advancing celltherapy
-
Health and medicine24 projects boosted by SCCCfunding
-
Health and medicineNew lab test for advancing cancertreatments
-
Health and medicineShocked, happy and a bit scared after landing 6 milliongrant
-
Health and medicineSEK 2.4 million for lung cancerresearch
-
Health and medicineSEK 11 million for research on unique cancertreatment
-
Health and medicineEffective treatment in rare but deadly form ofcancer
-
Health and medicineBest Scientific Paper on FundamentalResearch
-
Health and medicineGroundbreaking research on individually tailored precision medicine for treating lungcancer
-
Health and medicineProtective T cells remain 20 months afterCOVID-19
No events are currently published.
Latest SCCR publications
- Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxic… (External link)
- Principles of digital sequencing using unique molecular identifiers (External link)
- MYB alternative promoter activity is increased in adenoid cystic carcinoma meta… (External link)
- The effect of a single dose of nivolumab prior to isolated limb perfusion for p… (External link)
- Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian… (External link)
- Digital RNA sequencing using unique molecular identifiers enables ultrasensitiv… (External link)
- Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as… (External link)
- SCC publications (before name change) (External link)
